Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial.
Williams JG, Alam MF, Alrubaiy L, Arnott I, Clement C, Cohen D, Gordon JN, Hawthorne AB, Hilton M, Hutchings HA, Jawhari AU, Longo M, Mansfield J, Morgan JM, Rapport F, Seagrove AC, Sebastian S, Shaw I, Travis SP, Watkins A.
Williams JG, et al. Among authors: cohen d.
Lancet Gastroenterol Hepatol. 2016 Sep;1(1):15-24. doi: 10.1016/S2468-1253(16)30003-6.
Lancet Gastroenterol Hepatol. 2016.
PMID: 27595142
Free PMC article.
Clinical Trial.